Search Result "NSCLC"


Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3894-3900
Author(s): Paolo Maione,Antonio Rossi,Marianna Bareschino,Paola Claudia Sacco,Clorinda Schettino,Francesca Casaluce,Assunta Sgambato,Cesare Gridelli

MET and ALK as Targets for the Treatment of NSCLC

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3914-3932
Author(s): Capelletti M,Gelsomino F.,Tiseo M.

Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to Work it Out?

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3863-3874
Author(s): Elena Galvani,Francesca Toffalorio,Godefridus J. Peters,Tommaso De Pas,Elisa Giovannetti

Signaling Intermediates (MAPK and PI3K) as Therapeutic Targets in NSCLC

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3944-3957
Author(s): Ludovica Ciuffreda,Ursula Cesta Incani,Linda S. Steelman,Stephen L. Abrams,Italia Falcone,Anais Del Curatolo,William H. Chappell,Richard A. Franklin,Sabrina Vari,Francesco Cognetti,James A. McCubrey,Michele Milella

Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3901-3913
Author(s): Massimo Di Maio,Alessandro Morabito,Maria Carmela Piccirillo,Gennaro Daniele,Pasqualina Giordano,Raffaele Costanzo,Claudia Sandomenico,Agnese Montanino,Gaetano Rocco,Francesco Perrone

Angiogenesis and Angiogenic Inhibitors in Non Small Cell Lung Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3 Issue: 2 Year: 2014 Page: 66-72
Author(s): Nawfel Mellas,Zineb Benbrahim,Abdul Rahman Jazieh

The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib

Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1322-1330
Author(s): Letizia Porcelli,Elisa Giovannetti,Yehuda G. Assaraf,Gerrit Jansen,George L. Scheffer,Ietje Kathman,Amalia Azzariti,Angelo Paradiso,Godefridus J. Peters

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

Journal: Current Cancer Drug Targets
Volume: 14 Issue: 9 Year: 2014 Page: 775-793
Author(s): Deepa Subramaniam,Aiwu R. He,Jimmy Hwang,John Deeken,Michael Pishvaian,Marion L. Hartley,John L. Marshall

The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?

Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1284-1292
Author(s): Francesco Passiglia,Nele Van Der Steen,Luis Raez,Patrick Pauwels,Ignacio Gil-Bazo,Edgardo Santos,Daniele Santini,Giovanni Tesoriere,Antonio Russo,Giuseppe Bronte,Karen Zwaenepoel,Federico Cappuzzo,Christian Rolfo

MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3982-3990
Author(s): D. Cortinovis,V. Monica,F Pietrantonio,G.L. Ceresoli,C.M. La Spina,L. Wannesson

Previous   Next

Go To   Results 1 - 1 of 140

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy